119 related articles for article (PubMed ID: 21198307)
21. Nutritional status of children during treatment for acute lymphoblastic leukemia in the Central American Pediatric Hematology Oncology Association (AHOPCA): preliminary data from Guatemala.
Antillon F; de Maselli T; Garcia T; Rossi E; Sala A
Pediatr Blood Cancer; 2008 Feb; 50(2 Suppl):502-5; discussion 517. PubMed ID: 18064654
[TBL] [Abstract][Full Text] [Related]
22. Outcomes of children with relapsed acute lymphoblastic leukemia in India.
Kulkarni KP; Marwaha RK
Asian Pac J Cancer Prev; 2011; 12(4):1101-2. PubMed ID: 21790259
[No Abstract] [Full Text] [Related]
23. Childhood acute myeloid leukemia: an Indian perspective.
Kulkarni KP; Marwaha RK
Pediatr Hematol Oncol; 2011 May; 28(4):257-68. PubMed ID: 21214409
[TBL] [Abstract][Full Text] [Related]
24. The impact of weight for age on survival in acute lymphoblastic leukemia: Report from a tertiary care center in North India.
Trehan A; Prabhu V; Bansal D
Indian J Cancer; 2015; 52(2):203-6. PubMed ID: 26853405
[TBL] [Abstract][Full Text] [Related]
25. Childhood acute lymphoblastic leukemia managed in tertiary care center in a developing country.
Dabbous IA; Dbouk H; Sibai AM; Bahlawan L
Med Pediatr Oncol; 2003 Jul; 41(1):83-4. PubMed ID: 12764756
[No Abstract] [Full Text] [Related]
26. Treatment of relapsed acute leukemia after allogeneic transplantation: a single center experience.
Arellano ML; Langston A; Winton E; Flowers CR; Waller EK
Biol Blood Marrow Transplant; 2007 Jan; 13(1):116-23. PubMed ID: 17222760
[TBL] [Abstract][Full Text] [Related]
27. Outcomes of Adults with Acute Lymphoblastic Leukemia After Autologous Hematopoietic Stem Cell Transplantation and the Significance of Pretransplantation Minimal Residual Disease: Analysis from a Single Center of China.
Ding Z; Han MZ; Chen SL; Ma QL; Wei JL; Pang AM; Zhang XY; Liang C; Yao JF; Cao YG; Feng SZ; Jiang EL
Chin Med J (Engl); 2015 Aug; 128(15):2065-71. PubMed ID: 26228220
[TBL] [Abstract][Full Text] [Related]
28. Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group.
Burkhardt B; Reiter A; Landmann E; Lang P; Lassay L; Dickerhoff R; Lakomek M; Henze G; von Stackelberg A
J Clin Oncol; 2009 Jul; 27(20):3363-9. PubMed ID: 19433688
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of lymphoid enhancer-binding factor-1 (LEF1) is a novel favorable prognostic factor in childhood acute lymphoblastic leukemia.
Jia M; Zhao HZ; Shen HP; Cheng YP; Luo ZB; Li SS; Zhang JY; Tang YM
Int J Lab Hematol; 2015 Oct; 37(5):631-40. PubMed ID: 25955539
[TBL] [Abstract][Full Text] [Related]
30. Long-term outcomes in survivors of childhood acute lymphoblastic leukemia.
Nathan PC; Wasilewski-Masker K; Janzen LA
Hematol Oncol Clin North Am; 2009 Oct; 23(5):1065-82, vi-vii. PubMed ID: 19825453
[TBL] [Abstract][Full Text] [Related]
31. Childhood acute lymphoblastic leukemia: refusal and abandonmentof treatment in the southeast of Iran.
Naderi M; Esmaeili Reykande S; Tabibian S; Alizadeh S; Dorgalaleh A; Shamsizadeh M
Turk J Med Sci; 2016 Apr; 46(3):706-11. PubMed ID: 27513245
[TBL] [Abstract][Full Text] [Related]
32. Significant male preponderance in childhood acute lymphoblastic leukemia in India and regional variation: tertiary care center experience, systematic review, and evaluation of population-based data.
Kulkarni KP; Marwaha RK
Pediatr Hematol Oncol; 2013 Sep; 30(6):557-67. PubMed ID: 23528149
[TBL] [Abstract][Full Text] [Related]
33. Progress in the treatment of adults with acute lymphoblastic leukemia.
Larson S; Stock W
Curr Opin Hematol; 2008 Jul; 15(4):400-7. PubMed ID: 18536580
[TBL] [Abstract][Full Text] [Related]
34. Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia.
Brissot E; Labopin M; Beckers MM; Socié G; Rambaldi A; Volin L; Finke J; Lenhoff S; Kröger N; Ossenkoppele GJ; Craddock CF; Yakoub-Agha I; Gürman G; Russell NH; Aljurf M; Potter MN; Nagler A; Ottmann O; Cornelissen JJ; Esteve J; Mohty M
Haematologica; 2015 Mar; 100(3):392-9. PubMed ID: 25527562
[TBL] [Abstract][Full Text] [Related]
35. Seasonality in diagnosis of childhood acute lymphoblastic leukemia: impact on disease presentation, survival outcome and resources.
Kulkarni KP; Marwaha RK
J Pediatr Hematol Oncol; 2013 Jan; 35(1):81-2. PubMed ID: 23242329
[No Abstract] [Full Text] [Related]
36. Treating leukemia in a resource poor setting.
Menon J; Mathews L; Purushothaman KK
Indian Pediatr; 2008 May; 45(5):410-2. PubMed ID: 18515933
[TBL] [Abstract][Full Text] [Related]
37. Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study.
Nguyen K; Devidas M; Cheng SC; La M; Raetz EA; Carroll WL; Winick NJ; Hunger SP; Gaynon PS; Loh ML;
Leukemia; 2008 Dec; 22(12):2142-50. PubMed ID: 18818707
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of plasma levels of thrombomodulin and von Willebrand factor in Egyptian children with acute lymphoblastic leukemia.
Hagag AA; Abdel-Lateef AE; Aly R
J Oncol Pharm Pract; 2014 Oct; 20(5):356-61. PubMed ID: 24243921
[TBL] [Abstract][Full Text] [Related]
39. IGH@ translocations, CRLF2 deregulation, and microdeletions in adolescents and adults with acute lymphoblastic leukemia.
Moorman AV; Schwab C; Ensor HM; Russell LJ; Morrison H; Jones L; Masic D; Patel B; Rowe JM; Tallman M; Goldstone AH; Fielding AK; Harrison CJ
J Clin Oncol; 2012 Sep; 30(25):3100-8. PubMed ID: 22851563
[TBL] [Abstract][Full Text] [Related]
40. The influence of maximum supportive care on dose compliance and survival. Single-center analysis of childhood acute lymphoblastic leukemia and non-Hodgkin's-lymphoma treated within 1984-1993.
Urban C; Benesch M; Lackner H; Schwinger W; Kerbl R; Gadner H
Klin Padiatr; 1997; 209(4):235-42. PubMed ID: 9293456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
